Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

Johannes Schetelig; Jennifer Hoek; Stephan Stilgenbauer; Jan Moritz Middeke; Niels Smedegaard Andersen; Christopher P Fox; Stig Lenhoff; Liisa Volin; Avichai Shimoni; Wilfried Schroyens; Michel van Gelder; Donald Bunjes; Anja van Biezen; Henning Baldauf; Liesbeth C de Wreede; Olivier Tournilhac; Nicolaus Kröger; Ibrahim Yakoub-Agha; Peter Dreger

doi:10.1038/s41409-020-01013-y

Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

Bone Marrow Transplant. 2021 Mar;56(3):692-695. doi: 10.1038/s41409-020-01013-y. Epub 2020 Aug 16.

Authors

Johannes Schetelig^{1

2

3

4}, Jennifer Hoek^{5

6}, Stephan Stilgenbauer^{7

8}, Jan Moritz Middeke⁹, Niels Smedegaard Andersen^{5

7

10}, Christopher P Fox^{5

11}, Stig Lenhoff^{5

12}, Liisa Volin^{5

7

13}, Avichai Shimoni^{5

14}, Wilfried Schroyens^{5

15}, Michel van Gelder^{5

7

16}, Donald Bunjes^{5

8}, Anja van Biezen^{5

6}, Henning Baldauf¹⁷, Liesbeth C de Wreede^{17

18}, Olivier Tournilhac^{5

7

19}, Nicolaus Kröger^{5

20}, Ibrahim Yakoub-Agha^{5

21}, Peter Dreger^{5

7

22}

Affiliations

¹ University Hospital, Dresden, Germany. johannes.schetelig@uniklinikum-dresden.de.
² DKMS Clinical Trials Office, Dresden, Germany. johannes.schetelig@uniklinikum-dresden.de.
³ European Society for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands. johannes.schetelig@uniklinikum-dresden.de.
⁴ European Research Initiative on Chronic Lymphocytic Leukemia (ERIC), Barcelona, Spain. johannes.schetelig@uniklinikum-dresden.de.
⁵ European Society for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands.
⁶ EBMT Data Office, Leiden, The Netherlands.
⁷ European Research Initiative on Chronic Lymphocytic Leukemia (ERIC), Barcelona, Spain.
⁸ Ulm University, Ulm, Germany.
⁹ University Hospital, Dresden, Germany.
¹⁰ Rigshospitalet, Copenhagen, Denmark.
¹¹ Nottingham University Hospitals NHS Trust, Nottingham, UK.
¹² University Hospital Lund, Lund, Sweden.
¹³ Helsinki University Central Hospital, Helsinki, Finland.
¹⁴ Chaim Sheba Medical Center, Tel-Hashomer, Israel.
¹⁵ Antwerp University Hospital, Edegem, Belgium.
¹⁶ University Medical Center Maastricht, Maastricht, The Netherlands.
¹⁷ DKMS Clinical Trials Office, Dresden, Germany.
¹⁸ Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
¹⁹ Service Therapie Cellulaire & Hematologie Clinique, Centre Hospitalier Universitaire, Clermont Ferrand, France.
²⁰ University Hamburg Eppendorf, Hamburg, Germany.
²¹ Centre Hospitalier Universitaire de Lille, LIRIS, INSERM U995, Université de Lille, Lille, France.
²² Department of Medicine V, University of Heidelberg, Heidelberg, Germany.

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
Leukemia, Lymphocytic, Chronic, B-Cell* / therapy
Prospective Studies
Transplantation, Homologous
Tumor Suppressor Protein p53 / genetics

Substances

TP53 protein, human
Tumor Suppressor Protein p53